Abstract
EVIDENCE-BASED ANSWER In patients with type 2 diabetes (T2DM) not requiring insulin, self-monitoring of blood glucose (SMBG) has inconsistent effects on patient-oriented outcomes such as quality of life (QOL), hypoglycemia, and patient satisfaction. The effect of SMBG is also inconsistent on all-cause mortality and diabetic complications. SMBG is associated with small but clinically insignificant reductions in hemoglobin A1C (HbA1C) (SOR: C, metaanalysis of RCTs with disease-oriented outcomes).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Evidence-based practice : patient-oriented evidence that matters
Paper Title
Journal
Date
